Kathleen McGroddy-Goetz - 08 Jun 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
s/ David B. Berger, Attorney-in-Fact for Kathleen McGroddy-Goetz
Issuer symbol
TNDM
Transactions as of
08 Jun 2021
Net transactions value
$0
Form type
4
Filing time
10 Jun 2021, 16:56:58 UTC
Previous filing
20 May 2021
Next filing
16 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +1,219 $0.000000 1,219 08 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -1,219 -33% $0.000000 2,440 08 Jun 2021 Common Stock 1,219 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F2 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company.
F3 This RSU award was granted on June 8, 2020. 33% of the RSU vested on June 8, 2021 and the remaining 67% will vest annually over the next two years.
F4 The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.